Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II Studies

This study has been completed.
Sponsor:
Information provided by:
Wayne State University
ClinicalTrials.gov Identifier:
NCT01020370
First received: November 24, 2009
Last updated: NA
Last verified: November 2009
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given